Clear evidence. Transparent sources. Practical guidance. Our evidence policyContact
Food Health Lab
HomeSupplementsBrain & cognition › Magnesium-L-threonate

Magnesium-L-threonate

Sold as “the magnesium that gets into your brain.” The rat studies are impressive; the human evidence is one small, sponsor-linked trial — and it costs several times more than the magnesium you already have.

Reviewed by Bodil Isaksson, Licensed Biomedical Scientist (Sweden)Last reviewed July 2026Supplement guide

SupplementsBrain & cognitionThin evidence

Magnesium-L-threonate (brand name Magtein) was designed at MIT specifically to raise magnesium levels in the brain, and in aged rats it did exactly that, improving memory. It is a clever molecule with a clean origin story, which is precisely why it commands a premium price. But a supplement stands or falls on human trials, and here there is almost nothing — one small study, closely tied to the people who sell it. Before paying up, it is worth separating the elegant science from the marketing built on top of it.

Key takeaways

  • The headline “raises brain magnesium and improves memory” data are from rodents.1
  • Human evidence is essentially one small trial with industry ties — nowhere near enough to justify the marketing.2
  • If you are magnesium-deficient, any cheaper well-absorbed form (glycinate, citrate) corrects that — see the magnesium guide.
  • It costs several times more per dose than ordinary magnesium, and delivers relatively little elemental magnesium per gram.

The pitch, and where it comes from

The selling point is bioavailability to the brain: threonate is proposed to ferry magnesium across the blood–brain barrier better than other salts, raising magnesium in the cerebrospinal fluid. In a well-known study, aged rats given magnesium-L-threonate increased brain magnesium and performed better on learning and memory tasks, with signs of restored synaptic density.1 That is a real, interesting finding — in rats. The entire consumer proposition rests on assuming it transfers to humans, which is exactly the step that has barely been tested.

What humans actually show

The human record is thin enough to state in a sentence: a single small clinical trial in older adults with memory complaints reported cognitive improvement over 12 weeks — a study conducted with involvement from parties connected to the product.2 There is no large independent replication, no long-term data, and no evidence it prevents cognitive decline or dementia. On the evidence ladder used across this section, that places it firmly in the “interesting, unproven” category — a long way below creatine or DHA, both of which have multiple independent human trials.

Fix a real deficiency first

Here is the practical point the marketing skips: magnesium’s well-established benefits — on sleep, muscle cramps, blood pressure, migraine — come from correcting an actual shortfall, and plenty of people fall short. If that is you, a cheap, well-absorbed everyday form like magnesium glycinate or citrate does the job for a fraction of the price. There is no evidence that the threonate form beats these for anything outside the specific brain-magnesium hypothesis, so start with the basics on the magnesium page before paying up for the premium version.

Dose, cost and safety

The typical dose mirrors the trial: about 1.5–2 g/day of magnesium-L-threonate, which supplies only around 140–150 mg of elemental magnesium — a modest amount for a large, pricey capsule count. Safety-wise it behaves like other oral magnesium: the main effect at higher doses is loose stools, and people with significant kidney impairment should not supplement magnesium without medical guidance, as they cannot clear an excess. It is not dangerous; it is just expensive and, for now, largely unproven in people.

Bottom line: elegant rodent science, one small industry-linked human trial. If you need magnesium, a cheap glycinate or citrate does the job — there is no proven reason to pay a premium for the “brain” form yet.

References

Adult research summary for education, not a prescription. These are food supplements, not treatments for disease.

  1. Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron 2010;65(2):165–177. pubmed.ncbi.nlm.nih.gov
  2. Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults: a randomized, double-blind, placebo-controlled trial. J Alzheimers Dis, 2016;49(4):971–90. (Three of five authors affiliated with Neurocentria, Inc., which commercialises the compound; no conflict-of-interest statement filed.) pubmed.ncbi.nlm.nih.gov

This article summarises nutrition science for education. It is not a substitute for individual medical advice; consult a professional before starting a supplement, in pregnancy, or alongside medication.